HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulse radiolysis studies on the hypoxia-selective toxicity of a colbalt-mustard complex.

Abstract
The kinetic basis for the in vitro hypoxia-selective cytotoxicity (HSC) of the Co(III)-nitrogen mustard complex SN 24771 (NSC 675352) has been investigated using pulse radiolysis. The rate constants for the one-electron reduction of SN 24771 by model reductants exhibited a marked dependence on the one-electron reduction potential of the reductant, with values up to several orders of magnitude slower than for the nitroimidazole drug misonidazole. Following one-electron reduction to form the Co(II) complex (species I) consecutive conversion to further transient species (II and III) occurs with first order rate constants of 120 +/- 10 s-1 and 10 +/- 2 s-1 and are associated with release of ligands. Neither of these subsequent processes are inhibited by the addition of O2 up to a concentration of 0.5 mmol l-1 suggesting that the HSC action of SN 24771 most likely arises from a mechanism other than simple redox cycling between the Co(III) and Co(II) forms by O2. If the measured low rate constants of one-electron reduction by model reductants of SN 24771 (as compared to the reduction of nitroaromatics), is mirrored by biological reductants, then it is proposed that HSC may occur through competition between SN 24771 and O2 for these reductants.
AuthorsR F Anderson, W A Denny, D C Ware, W R Wilson
JournalThe British journal of cancer. Supplement (Br J Cancer Suppl) Vol. 27 Pg. S48-51 (Jul 1996) ISSN: 0306-9443 [Print] England
PMID8763845 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Nitrogen Mustard Compounds
  • Organometallic Compounds
  • SN 24771
Topics
  • Antineoplastic Agents (pharmacokinetics)
  • Cell Hypoxia
  • Nitrogen Mustard Compounds (pharmacokinetics, pharmacology)
  • Organometallic Compounds (pharmacokinetics, pharmacology)
  • Oxidation-Reduction
  • Pulse Radiolysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: